Anti-IL13 x Anti-IL4 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-IL13 and anti-IL4 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can block two proinflammatory cytokines simultaneously. It is designed for the research of Idiopathic pulmonary fibrosis therapy.
There are currently no customer reviews or questions for Human Anti-IL13 x Anti-IL4 Bispecific Antibody (IgG-IgG) (BSIG-H337). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS